CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

• Seth M Pollack,
• Robin L Jones,
• Marissa Vignali,
• Brett A Schroeder,
• Shihong Zhang,
• Jose G Mantilla,
• Kimberly S Smythe,
• Jean S Campbell,
• Robert H Pierce,
• Lee D Cranmer,
• Michael J Wagner,
• Bonnie J LaFleur,
• Brian C Schulte,
• Natalie A LaFranzo,
• Rachel M Gittelman,
• Kevin C Flanagan,
• Julie Rytlewski,
• Laura Riolobos,
• Teresa S Kim,
• Eleanor Chen

Affiliations

Seth M Pollack

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Robin L Jones

Sarcoma, Royal Marsden Hospital and Institute of Cancer Research, London, UK

Marissa Vignali

Aff2 grid.421940.aAdaptive Biotechnologies Corporation Seattle WA USA

Brett A Schroeder

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

Shihong Zhang

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

Jose G Mantilla

Pathology, University of Washington Medical Center, Seattle, Washington, USA

Kimberly S Smythe

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Jean S Campbell

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Robert H Pierce

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

Lee D Cranmer

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

Michael J Wagner

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Bonnie J LaFleur

2Division of Epidemiology and Biostatistics, University of Arizona, Tuscon, Arizona, USA

Brian C Schulte

Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

Natalie A LaFranzo

Cofactor Genomics, San Francisco, California, USA

Rachel M Gittelman

Adaptive Biotechnologies Corp, Seattle, Washington, USA

Kevin C Flanagan

Cofactor Genomics, San Francisco, California, USA

Julie Rytlewski

Bristol Myers Squibb, Seattle, Washington, USA

Laura Riolobos

UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington, USA

Teresa S Kim

Department of Surgery, University of Washington, Seattle, Washington, USA

Eleanor Chen

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA